Boric acid (BA) is a naturally occurring agent used in manufacturing processes and numerous consumer products. Because of the potential for both industrial and consumer exposure to boron-containing compounds, and the lack of developmental toxicity data, the National Toxicology Program evaluated the potential for boric acid to cause developmental toxicity in pregnant Swiss (CD-1) mice, Sprague-Dawley rats (n = 26-28/group), and New Zealand rabbits (n = 1 8-23/group). BA was provided in the feed to mice and rats at 0, 0.1, 0.2, or 0.4% throughout gestation to attain steadystate exposure as early as possible during development. Average doses (mg/kg/day) were 248, 452, or 1003 for mice, and 78, 163, or 330 in rats. A separate group of rats received 0.8% BA in the feed, or 539 mg/kg/day only on gestation days (gd) 6 to 15. Rabbits were given BA (0, 62.5, 125, or 250 mg/kg) by gavage administration on gd 6 to 19. Maternal body weight, food and/or water consumption and signs of toxicity were monitored at regular intervals. At termination, gd 17 (mice), 20 (rats), or 30 (rabbits), the uterus was examined to determine the number of resorptions, dead, or live fetuses. Fetuses were weighed and live fetuses were examined for external, visceral, and skeletal defects. Mouse dams exhibited mild renal lesions (.248 mg/kg/day BA), increased water intake and relative kidney weight (1003 mg/kg/day BA), and decreased weight gain during treatment. Maternal rats exhibited increased liver and kidney weights at 2163 mg/kg/day BA, altered water and/or food intake at >163 mg/kg/day BA, and decreased weight gain at >330 mg/kg/day BA. In rabbits, signs of toxicity included decreased food consumption during treatment, and vaginal bleeding associated with pregnancy loss at 250 mg/kg/day. Maternal body weight (gd 9 to 30), weight gain during treatment, and gravid uterine weight decreased at 250 mg/kg/day. Relative maternal kidney weight (but not absolute weight) was increased at 250 mg/kg/day, but microscopic evaluation did not indicate any renal pathology associated with BA exposure. BA is a developmental toxicant in all three species. The lowestobserved-adverse-effect level (LOAEL) for developmental toxicity was 78 mg/kg/day for rats (fetal weight reduction), 250 mg/kg/day for rabbits (prenatal mortality and malformations), and 452 mg/kg/day for mice (fetal weight reduction). The no-observed-adverse-effect levels (NOAELs) for developmental toxicity in these species were <78 mg/kg/day (rats), 125 mg/kg/day (rabbits), and 248 mg/kg/day (mice). With regard to maternal toxicity, the rat was the most sensitive (163 mg/kg/day), while both the mouse and rabbit showed maternal toxicity at 250 mg/kg/day. Thus, developmental toxicity occurred below maternally toxic levels in the rat, and only in the presence of maternal toxicity in mice or rabbits. -Environ Health Perspect 102(Suppl 7): 107-112 (1994) 
Introduction
Boric acid is a naturally occurring agent used in manufacturing processes and numerous consumer products (1) (2) (3) . At high concentrations, boric acid is a reproductive toxicant in mice (4) and rats (5) (6) (7) . While males appear to be the predominandy affected sex (4) , other investigators have shown that pregnancy in mice can also be disrupted by boric acid exposure. A single dose of boric acid (500-3000 mg/kg) to mice on the first day of pregnancy disrupted pregnancy because of failure of blastulation in mice (2) . There is also evidence that boric acid decreased ovulation in rats (3) . Teratogenic effects such as rumplessness and microphthalmia have been reported in chick embryos treated with boric acid (8, 9) . There has been a report of increased malformations (especially congenital cataracts) among children of pregnant women who used boric acid as a topical antimicrobial agent (10) .
Because of the high industrial production of boric acid, the potential for human exposure to products containing boric acid, and data indicating the reproductive toxicity and possible developmental toxicity of boric acid, the National Toxicology Program (NTP) designed studies to define the potential for boric acid to cause developmental toxicity in mice, rats, and rabbits. This was accomplished in studies in which the females were dosed orally with boric acid shortly after mating and continued until the day prior to natural parturition, or during any specific periods within this time frame. Both maternal and developmental toxicity end points were evaluated.
Detailed reports of these studies are available (11) (12) (13) and the studies in mice and rats have been published (14) . A summary of the results of these three studies is presented here. (Table 1) .
Materials and Methods
Treatment. Time-mated rats or mice were given boric acid in the feed continuously from the morning of gestation day (gd) 0 to the morning of gd 20 (17) (18) (19) (20) .
Statistics. Statistical analysis of the data was made as described previously, using the litter as the statistical unit (11) (12) (13) (14) (Table   3 ). However, boric acid treatment was associated with significant adverse postimplantation effects, particularly in the high-dose group. The percentage of resorptions per litter increased from 6% in the control group to 19% by exposure to 0.4% boric acid, and fetal body weight was reduced by 33% compared to controls. Treatment with 0.2% boric acid was also associated with a significant, but less severe, fetal body weight reduction of 11%.
Boric acid also had effects on fetal morphologic development. The most frequently observed malformations in the 0.4% boric acid-treated litters were skeletal defects, particularly short rib XIII (in the 4% dosage-treated fetuses). In contrast, the occurrences of fetuses per litter with malformations were fewer in the low-and middose group than in the control group. In particular, the incidence of full or rudimentary lumbar I rib(s) was observed less frequently in fetuses of boric acid-treated mice. The presence of a rib at lumbar I (classified as an anatomic variation in this species and strain) was decreased in a dose- (Table 4 ). In contrast, the incidence of late fetal deaths was low in all groups (<2.8% per litter) and showed no systematic relationship to boric acid exposure. Average fetal body weight per litter was 92% that of controls at the high dose, but this difference did not reach statistical significance. In part, the absence of a significant fetal weight effect reflects the small sample size for this parameter (only six litters in the high-dose group survived to gd 30, as compared to 18 to 23 litters in the other study groups).
Volume 102, Supplement 7, November 1994 (11 /14) in the control through high-dose groups, respectively (Table 4) . Malformations of the cardiovascular (CV) system (great vessels and heart) were the most frequently observed abnormality. A post hoc analysis of CV malformations revealed a significant increase in the incidence of fetuses per litter with major CV defects at the high dose (72 vs 3% for controls). CV malformations whose incidence appeared to be elevated by boric acid exposure (especially at the high dose) included interventricular septal defects in 0.6% of the control-group fetuses examined (1 / 159), and 57% (8 / 14) of the high-dose fetuses; an enlarged aorta in 0% (0/159), and 36% (5/14) of fetuses examined in control and high-dose groups, respectively.
The percentage of fetuses with anatomical variations was not significantly elevated above that of controls in any of the boric acid-exposed groups.
Discussion
Three mammalian species have been evaluated during gestation for developmental toxicity of boric acid at exposure levels which did not cause maternal mortality (Table 5 ). In all three species, boric acid was developmentally toxic to the developing embryo /fetus. In two of the species, mice and rabbits, the developmental toxicity occurred at doses which were high enough to cause some maternal toxicity. In rats, minimal developmental toxicity (a 6% decrease in fetal weight) was measured at a dosage of 78 mg/kg/day in the absence of detectable maternal toxicity. In comparing the results of these three studies, it is important to note that the rat and mouse studies were feed studies, while the rabbit study was a gavage study. Extrapolating from the data of Treinen and Chapin (7) , it is probable that the rodents reached steady-state blood and tissue levels of boric acid by the fourth day of exposure. While kinetic data following once-a-day gavage studies are not available, one would expect the profile of blood levels to be substantially different from those of a feed study. Thus, while some of the dose levels (mg/kg/day) overlap, one cannot assume comparable exposures at critical target sites.
Nonetheless, a comparison in Table 5 shows that the lowest-observed-adverseeffect levels (LOAELs) for developmental toxicity were 78 mg/kg/day for rats (fetal weight reduction), 250 mg/kg/day for rabbits (prenatal mortality and malformations) and 452 mg/kg/day for mice (fetal weight reduction). The no-observedadverse-effect level (NOAELs) for developmental toxicity were <78 mg/kg/day (rats), 125 mg/kg/day (rabbits), and 248 mg/kg/day (mice). Rabbits were the species most sensitive to boric acid-induced prenatal mortality and malformations, while mice were the most resistant, based on the doses and routes of administration employed in these studies.
Boric acid treatment of rats and mice resulted in increased resorptions in the presence of normal numbers of implantation sites, decreased fetal weights, and increased numbers of malformations. The predominant malformation in both species was agenesis, or shortening of the 13th rib, Environmental Health Perspectives 
